APOSAVE
DEAD

Serial Number

76481425

Owner

NEURONZ LIMITED

Attorney

Vincent T. Pace

Filing Date

Jan 10, 2003

Add to watchlist:

No watchlists yet
View on USPTO

APOSAVE Trademark

Serial Number: 76481425 • Registration: 3447276

APOSAVE is a trademark filed by NEURONZ LIMITED on January 10, 2003. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NEURONZ LIMITED (2 trademarks)

Level 3, 2-6 Park Avenue
Grafton, Auckland , NZ

Entity Type: 03

Trademark Details

Filing Date

January 10, 2003

Registration Date

June 17, 2008

Published for Opposition

April 1, 2008

Cancellation Date

January 23, 2015

Goods & Services

Pharmaceutical and veterinary preparations for neuroprotective purposes, namely; pharmaceutical preparations and substances for the treatment of brain injury, nervous system disorders, and autoimmune diseases; pharmaceutical preparations for the protection and preservation of the nervous system; pharmaceutical preparations for monitoring of the nervous system

Filing History

CANCELLED SEC. 8 (6-YR)
Jan 23, 2015 C8..
REGISTERED-PRINCIPAL REGISTER
Jun 17, 2008 R.PR
PUBLISHED FOR OPPOSITION
Apr 1, 2008 PUBO
NOTICE OF PUBLICATION
Mar 12, 2008 NPUB
ELECTRONIC RECORD REVIEW COMPLETE
Feb 25, 2008 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Feb 22, 2008 ERRR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 18, 2005 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 6, 2004 CNSA
EXAMINERS AMENDMENT E-MAILED
Sep 28, 2004 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 28, 2004 CNEA
ASSIGNED TO LIE
Aug 31, 2004 ALIE
PETITION TO REVIVE-GRANTED
Aug 2, 2004 PETG
PETITION TO REVIVE-RECEIVED
Mar 12, 2004 PETR
PAPER RECEIVED
Mar 12, 2004 MAIL
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 1, 2004 ABN2
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 27, 2003 TCCA
NON-FINAL ACTION E-MAILED
Jul 2, 2003 GNRT
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 1, 2003 CRFA
PAPER RECEIVED
May 1, 2003 MAIL
NON-FINAL ACTION E-MAILED
Mar 20, 2003 GNRT
ASSIGNED TO EXAMINER
Mar 18, 2003 DOCK